My complaint concerned AEX.The ASX reviewed my concerns and found the company to be compliant with the listing rules.I am now editing my letter and will send it to ASIC today.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%